Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
Diabetes Care - United States
doi 10.2337/dc18-1578
Full Text
Open PDFAbstract
Available in full text
Date
May 21, 2019
Authors
Publisher
American Diabetes Association